|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001792,
umls-concept:C0007131,
umls-concept:C0030705,
umls-concept:C0036525,
umls-concept:C0045093,
umls-concept:C0078257,
umls-concept:C0087111,
umls-concept:C0149925,
umls-concept:C0282460,
umls-concept:C0332283,
umls-concept:C1518422,
umls-concept:C1518965,
umls-concept:C1522484,
umls-concept:C1705294
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-6-13
|
|
pubmed:abstractText |
High risk patients with metastatic non small cell lung cancer (NSCLC) including patients with performance status (PS) 2 or elderly with comorbidities do poorly on combination chemotherapy regimens. We evaluated a sequential treatment with Vinorelbine followed by Gemcitabine to determine its effect on survival and the toxicity in this patient population.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0169-5002
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
117-23
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15949597-Adult,
pubmed-meshheading:15949597-Age Factors,
pubmed-meshheading:15949597-Aged,
pubmed-meshheading:15949597-Aged, 80 and over,
pubmed-meshheading:15949597-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15949597-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:15949597-Comorbidity,
pubmed-meshheading:15949597-Deoxycytidine,
pubmed-meshheading:15949597-Drug Administration Schedule,
pubmed-meshheading:15949597-Female,
pubmed-meshheading:15949597-Frail Elderly,
pubmed-meshheading:15949597-Humans,
pubmed-meshheading:15949597-Infusions, Intravenous,
pubmed-meshheading:15949597-Lung Neoplasms,
pubmed-meshheading:15949597-Male,
pubmed-meshheading:15949597-Middle Aged,
pubmed-meshheading:15949597-Palliative Care,
pubmed-meshheading:15949597-Risk Factors,
pubmed-meshheading:15949597-Survival Analysis,
pubmed-meshheading:15949597-Treatment Outcome,
pubmed-meshheading:15949597-Vinblastine
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Sequential therapy with Vinorelbine followed by Gemcitabine in patients with metastatic non small cell lung cancer (NSCLC), performance status (PS) 2, or elderly with comorbidities--a multicenter phase II trial.
|
|
pubmed:affiliation |
Royal Victoria Hospital, McGill University, 687 Pine Avenue W, Montreal, Que., Canada H3A 1A1. vera.hirsh@muhc.mcgill.ca
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
